Study: Protein patterns help doctors distinguish bladder cancer cases:
This article was originally published in Clinica
US researchers have identified a pattern of 22 proteins that could help distinguish patients with bladder cancer from individuals with other malignant and non-malignant genitourinary diseases. Their specific protein pattern model allowed them to correctly identify in urine samples between 86% and 100% of 31 patients with urothelial carcinoma, 138 people who had other genitourinary diseases, and 11 healthy individuals. The findings, by a team from the University of Virginia Health Sciences Center, in Charlottesville, appear in the March issue of The Lancet Oncology.
You may also be interested in...
Women implanted with Bayer’s Essure birth-control device have significantly higher rates of pelvic pain, uterine bleeding and hypersensitivity compared to women who undergo tubal ligation, according to initial results from a government-mandated postmarket study. See what US FDA’s spokeswoman Alison Hunt said about it here.
Companies developing antibiotics to get financial and technical support from more than 20 firms contributing to new AMR Action Fund. Initiative is also pushing for reimbursement reform and other policies to support commercial marketing.
Joe Biden’s presidential campaign now has a plan to address supply chains and encourage US-based manufacturing of prescription drugs. That affirms the unlikely national prominence of the issue – and reduces the chances of meaningful legislation this year.